Ophthalmic Business News

The FDA granted investigational drug clearance to HG202, a CRISPR/Cas13Y RNA-editing therapy for neovascular age-related macular degeneration, according to a press release from HuidaGene.

The FDA granted fast track designation to FLQ-101 for the treatment of retinopathy of prematurity, according to a press release from FELIQS.

CHICAGO — In this Healio Video Perspective from Eyecelerator@AAO, Oculis CEO Riad Sherif, MD, provides a status report on OCS-01, OCS-02 and OCS-05 eye drops.

As a physician, your career will be rewarding in many ways, including a personal sense of purpose, ability to help others and the potential for high-earning power.

Brenting: v. To make bold and audacious deals in the eye care space.

CHICAGO — In this Healio Video Perspective from Eyecelerator@AAO, Alex Long of Alcon introduces some of the company’s technologies, including the Voyager direct selective laser trabeculoplasty device.

In this episode, John A. Hovanesian, MD, FACS, and Jim Mazzo discuss the latest news and trends and chat with Tom Mitro about his career and impact in ophthalmology.

CHICAGO — In this Healio Video Perspective from Eyecelerator@AAO, Sam Barone, MD, of Nanoscope Therapeutics discusses the mutation-agnostic gene therapy MCO-010.

CHICAGO — In this Healio Video Perspective from Eyecelerator@AAO, Nordic Pharma Eye Care U.S. president Philip Gioia and chief commercial officer Jai G. Parekh, MD, MBA, FAAO, discuss Lacrifill’s launch and its impact on dry eye treatment.

Science Corporation reported positive preliminary results of a clinical trial examining its Prima retinal implant in patients with central visual field loss due to geographic atrophy.